Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.07
STJ's Cash to Debt is ranked lower than
94% of the 319 Companies
in the Global Medical Devices industry.

( Industry Median: 2.42 vs. STJ: 0.07 )
Ranked among companies with meaningful Cash to Debt only.
STJ' s Cash to Debt Range Over the Past 10 Years
Min: 0.01  Med: 0.34 Max: No Debt
Current: 0.07
Equity to Asset 0.34
STJ's Equity to Asset is ranked lower than
87% of the 294 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. STJ: 0.34 )
Ranked among companies with meaningful Equity to Asset only.
STJ' s Equity to Asset Range Over the Past 10 Years
Min: 0.31  Med: 0.55 Max: 0.83
Current: 0.34
0.31
0.83
Interest Coverage 7.64
STJ's Interest Coverage is ranked lower than
75% of the 195 Companies
in the Global Medical Devices industry.

( Industry Median: 38.74 vs. STJ: 7.64 )
Ranked among companies with meaningful Interest Coverage only.
STJ' s Interest Coverage Range Over the Past 10 Years
Min: 9.03  Med: 15.50 Max: 24.41
Current: 7.64
9.03
24.41
F-Score: 6
Z-Score: 2.91
M-Score: -2.44
WACC vs ROIC
8.62%
9.89%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 16.08
STJ's Operating margin (%) is ranked higher than
85% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 2.65 vs. STJ: 16.08 )
Ranked among companies with meaningful Operating margin (%) only.
STJ' s Operating margin (%) Range Over the Past 10 Years
Min: 15.01  Med: 20.23 Max: 24.73
Current: 16.08
15.01
24.73
Net-margin (%) 11.40
STJ's Net-margin (%) is ranked higher than
80% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 1.06 vs. STJ: 11.40 )
Ranked among companies with meaningful Net-margin (%) only.
STJ' s Net-margin (%) Range Over the Past 10 Years
Min: 8.09  Med: 15.34 Max: 17.82
Current: 11.4
8.09
17.82
ROE (%) 16.31
STJ's ROE (%) is ranked higher than
85% of the 297 Companies
in the Global Medical Devices industry.

( Industry Median: 1.21 vs. STJ: 16.31 )
Ranked among companies with meaningful ROE (%) only.
STJ' s ROE (%) Range Over the Past 10 Years
Min: 11.45  Med: 18.85 Max: 23.77
Current: 16.31
11.45
23.77
ROA (%) 5.60
STJ's ROA (%) is ranked higher than
69% of the 319 Companies
in the Global Medical Devices industry.

( Industry Median: -0.01 vs. STJ: 5.60 )
Ranked among companies with meaningful ROA (%) only.
STJ' s ROA (%) Range Over the Past 10 Years
Min: 6.39  Med: 9.57 Max: 12.8
Current: 5.6
6.39
12.8
ROC (Joel Greenblatt) (%) 32.51
STJ's ROC (Joel Greenblatt) (%) is ranked higher than
82% of the 314 Companies
in the Global Medical Devices industry.

( Industry Median: 4.86 vs. STJ: 32.51 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
STJ' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 33.49  Med: 41.70 Max: 55.1
Current: 32.51
33.49
55.1
Revenue Growth (3Y)(%) 3.50
STJ's Revenue Growth (3Y)(%) is ranked lower than
52% of the 232 Companies
in the Global Medical Devices industry.

( Industry Median: 3.90 vs. STJ: 3.50 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
STJ' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 3.5  Med: 11.20 Max: 21
Current: 3.5
3.5
21
EBITDA Growth (3Y)(%) 3.30
STJ's EBITDA Growth (3Y)(%) is ranked higher than
52% of the 194 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. STJ: 3.30 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
STJ' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -4.6  Med: 14.60 Max: 22.3
Current: 3.3
-4.6
22.3
EPS Growth (3Y)(%) 8.70
STJ's EPS Growth (3Y)(%) is ranked higher than
59% of the 195 Companies
in the Global Medical Devices industry.

( Industry Median: 3.20 vs. STJ: 8.70 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
STJ' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -36.1  Med: 13.10 Max: 117.9
Current: 8.7
-36.1
117.9
» STJ's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-10-21)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q2 2015

STJ Guru Trades in Q2 2015

John Keeley 6,310 sh (New)
Jim Simons 271,613 sh (+33.73%)
Vanguard Health Care Fund 6,123,679 sh (+1.66%)
Ken Fisher 244,647 sh (+0.13%)
John Buckingham Sold Out
John Rogers 1,277,638 sh (-0.23%)
Barrow, Hanley, Mewhinney & Strauss 2,987,693 sh (-1.42%)
Mairs and Power 2,044,623 sh (-8.48%)
Jeremy Grantham 1,325,370 sh (-12.50%)
Mario Gabelli 8,400 sh (-32.26%)
David Dreman 19,384 sh (-33.05%)
Paul Tudor Jones 11,850 sh (-62.69%)
Louis Moore Bacon 90,000 sh (-70.00%)
Joel Greenblatt 72,464 sh (-91.83%)
» More
Q3 2015

STJ Guru Trades in Q3 2015

RS Investment Management 70,900 sh (New)
Ray Dalio 55,216 sh (New)
John Hussman 70,000 sh (New)
John Keeley 7,835 sh (+24.17%)
Ken Fisher 260,791 sh (+6.60%)
John Rogers 1,323,958 sh (+3.63%)
Barrow, Hanley, Mewhinney & Strauss 2,990,096 sh (+0.08%)
Mario Gabelli 8,400 sh (unchged)
Vanguard Health Care Fund 6,123,679 sh (unchged)
Louis Moore Bacon Sold Out
Mairs and Power 2,026,648 sh (-0.88%)
Jim Simons 265,813 sh (-2.14%)
David Dreman 18,285 sh (-5.67%)
Jeremy Grantham 863,696 sh (-34.83%)
Paul Tudor Jones 6,353 sh (-46.39%)
Joel Greenblatt 9,860 sh (-86.39%)
» More
Q4 2015

STJ Guru Trades in Q4 2015

Jeff Auxier 22,019 sh (New)
Joel Greenblatt 32,724 sh (+231.89%)
Jim Simons 806,113 sh (+203.26%)
Ray Dalio 77,167 sh (+39.75%)
John Keeley 9,315 sh (+18.89%)
Mairs and Power 2,258,163 sh (+11.42%)
John Rogers 1,333,643 sh (+0.73%)
Vanguard Health Care Fund 6,123,679 sh (unchged)
Mario Gabelli 8,400 sh (unchged)
John Hussman Sold Out
David Dreman Sold Out
Barrow, Hanley, Mewhinney & Strauss 2,978,770 sh (-0.38%)
Ken Fisher 255,140 sh (-2.17%)
Jeremy Grantham 792,255 sh (-8.27%)
Paul Tudor Jones 5,529 sh (-12.97%)
RS Investment Management 48,940 sh (-30.97%)
» More
Q1 2016

STJ Guru Trades in Q1 2016

David Dreman 17,529 sh (New)
Leucadia National 4,700 sh (New)
Steven Cohen 3,200 sh (New)
John Keeley 23,950 sh (+157.11%)
Jim Simons 1,920,213 sh (+138.21%)
Ray Dalio 114,830 sh (+48.81%)
Jeff Auxier 31,972 sh (+45.20%)
John Rogers 1,850,653 sh (+38.77%)
Mairs and Power 2,936,518 sh (+30.04%)
Ken Fisher 258,311 sh (+1.24%)
Barrow, Hanley, Mewhinney & Strauss 2,983,270 sh (+0.15%)
Vanguard Health Care Fund 6,123,679 sh (unchged)
Mario Gabelli 8,400 sh (unchged)
RS Investment Management Sold Out
Paul Tudor Jones Sold Out
Joel Greenblatt Sold Out
Jeremy Grantham 757,155 sh (-4.43%)
» More
» Details

Insider Trades

Latest Guru Trades with STJ

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices
Compare:NYSE:EW, NYSE:ZBH, NAS:ISRG, NYSE:SNN, NYSE:BSX, OTCPK:SONVY, NYSE:VAR, NYSE:TFX, NAS:ALGN, OTCPK:SDMHF, OTCPK:CHEOY, OTCPK:WILLF, NAS:ABMD, OTCPK:FSPKF, NAS:NUVA, OTCPK:EKTAY, NAS:IART, OTCPK:GGNDF, NYSE:SYK, OTCPK:SHWGY » details
Traded in other countries:JUD.Germany,
St Jude Medical Inc develops, manufactures and distributes cardiovascular medical devices for global cardiac rhythm management, cardiovascular, atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain.

St Jude Medical Inc was incorporated in Minnesota in 1976. It develops, manufactures and distributes cardiovascular medical devices for the cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain. The Company's two segments are the Implantable Electronic Systems Division and the Cardiovascular and Ablation Technologies Division. The Company's principal products in each business unit are as follows: Implantable Electronic Systems Division (IESD) - tachycardia implantable cardioverter defibrillator systems (ICDs), bradycardia pacemaker systems (pacemakers) and neurostimulation products (spinal cord and deep brain stimulation devices); and Cardiovascular and Ablation Technologies Division (CATD) - vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography (OCT) imaging products, vascular plugs and other vascular accessories), structural heart products (heart valve replacement and repair products and structural heart defect devices) and atrial fibrillation (AF) products (electrophysiology (EP) introducers and catheters, cardiac mapping, navigation and recording systems and ablation systems). Implantable Electronic Systems Division (IESD): IESD is focused on the cardiac rhythm management and neuromodulation therapy areas. Cardiac rhythm management devices include ICDs that provide life-saving therapy to patients suffering from lethal heart conditions, such as sudden cardiac arrest; cardiac resynchronization therapy (CRT) devices to save and improve the lives of patients suffering from heart failure (HF); pacemakers to help patients whose hearts beat too slowly or who suffer from other debilitating cardiac arrhythmias; leads (wires that connect devices to the heart) to carry electrical impulses to the heart and provide information from the heart to the device; and programmers and remote monitoring equipment which are used by physicians and healthcare professionals to program is cardiac rhythm management devices and analyze device data to improve patient management. Neuromodulation product offerings provide neurostimulation treatment in which an implantable device delivers electrical current directly to targeted nerve sites. The Company's commercialized neurostimulation therapies include spinal cord stimulation (SCS) for the treatment of chronic pain, deep brain stimulation (DBS) for treating the symptoms of Parkinson's disease and peripheral nerve stimulation (PNS) for the treatment of chronic migraine headache. A neurostimulation system typically consists of four components: a pulse generator that produces the electrical current and is implanted under the patient's skin; implanted leads that carry the electrical impulses to the targeted nerve sites; an external patient remote control that enables the patient to control his or her therapy within prescribed ranges; and an external clinician pro

Top Ranked Articles about St Jude Medical Inc

Johnson & Johnson Reports 4% Sales Growth for the Second Quarter Pharmaceutical sales lead revenue higher for Johnson and Johnson
Johnson & Johnson (NYSE:JNJ) reported its second quarter 2016 earnings results on Tuesday, July 19. The company beat both revenue and earnings estimates for the quarter, helping to fuel continued momentum in U.S. stocks and the health care industry. For the quarter, revenue was $18.48 billion, beating analysts’ average estimate by $500 million. Revenue was also up 4% from the comparable quarter. Earnings for the second quarter were $1.74 beating analysts’ estimate by 6 cents. Read more...
Opinions Differ on Abbott Deal to Acquire St. Jude's Medical Abbott Laboratories aims for top cardiovascular medical devices market position
When you plan to acquire a company with the name St. Jude’s in it, you’d think the deal has to be blessed. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 36.11
STJ's P/E(ttm) is ranked lower than
65% of the 172 Companies
in the Global Medical Devices industry.

( Industry Median: 28.34 vs. STJ: 36.11 )
Ranked among companies with meaningful P/E(ttm) only.
STJ' s P/E(ttm) Range Over the Past 10 Years
Min: 12.69  Med: 21.53 Max: 51.47
Current: 36.11
12.69
51.47
Forward P/E 20.53
STJ's Forward P/E is ranked higher than
73% of the 55 Companies
in the Global Medical Devices industry.

( Industry Median: 24.63 vs. STJ: 20.53 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 36.11
STJ's PE(NRI) is ranked lower than
64% of the 171 Companies
in the Global Medical Devices industry.

( Industry Median: 28.88 vs. STJ: 36.11 )
Ranked among companies with meaningful PE(NRI) only.
STJ' s PE(NRI) Range Over the Past 10 Years
Min: 12.69  Med: 21.53 Max: 51.47
Current: 36.11
12.69
51.47
Price/Owner Earnings (ttm) 39.28
STJ's Price/Owner Earnings (ttm) is ranked lower than
59% of the 107 Companies
in the Global Medical Devices industry.

( Industry Median: 32.52 vs. STJ: 39.28 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
STJ' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 10.98  Med: 22.17 Max: 136.33
Current: 39.28
10.98
136.33
P/B 5.52
STJ's P/B is ranked lower than
71% of the 327 Companies
in the Global Medical Devices industry.

( Industry Median: 2.95 vs. STJ: 5.52 )
Ranked among companies with meaningful P/B only.
STJ' s P/B Range Over the Past 10 Years
Min: 2.13  Med: 4.07 Max: 6.83
Current: 5.52
2.13
6.83
P/S 4.18
STJ's P/S is ranked lower than
57% of the 320 Companies
in the Global Medical Devices industry.

( Industry Median: 3.51 vs. STJ: 4.18 )
Ranked among companies with meaningful P/S only.
STJ' s P/S Range Over the Past 10 Years
Min: 1.85  Med: 3.17 Max: 7
Current: 4.18
1.85
7
PFCF 32.05
STJ's PFCF is ranked lower than
52% of the 96 Companies
in the Global Medical Devices industry.

( Industry Median: 31.08 vs. STJ: 32.05 )
Ranked among companies with meaningful PFCF only.
STJ' s PFCF Range Over the Past 10 Years
Min: 9.96  Med: 21.08 Max: 41.71
Current: 32.05
9.96
41.71
POCF 24.89
STJ's POCF is ranked lower than
60% of the 134 Companies
in the Global Medical Devices industry.

( Industry Median: 20.58 vs. STJ: 24.89 )
Ranked among companies with meaningful POCF only.
STJ' s POCF Range Over the Past 10 Years
Min: 7.95  Med: 15.09 Max: 28.29
Current: 24.89
7.95
28.29
EV-to-EBIT 33.47
STJ's EV-to-EBIT is ranked lower than
65% of the 172 Companies
in the Global Medical Devices industry.

( Industry Median: 22.17 vs. STJ: 33.47 )
Ranked among companies with meaningful EV-to-EBIT only.
STJ' s EV-to-EBIT Range Over the Past 10 Years
Min: 10.1  Med: 19.30 Max: 33.8
Current: 33.47
10.1
33.8
EV-to-EBITDA 23.72
STJ's EV-to-EBITDA is ranked lower than
64% of the 181 Companies
in the Global Medical Devices industry.

( Industry Median: 18.09 vs. STJ: 23.72 )
Ranked among companies with meaningful EV-to-EBITDA only.
STJ' s EV-to-EBITDA Range Over the Past 10 Years
Min: 8.5  Med: 15.20 Max: 27.9
Current: 23.72
8.5
27.9
PEG 18.22
STJ's PEG is ranked lower than
91% of the 74 Companies
in the Global Medical Devices industry.

( Industry Median: 3.18 vs. STJ: 18.22 )
Ranked among companies with meaningful PEG only.
STJ' s PEG Range Over the Past 10 Years
Min: 0.72  Med: 1.49 Max: 21.13
Current: 18.22
0.72
21.13
Shiller P/E 33.81
STJ's Shiller P/E is ranked higher than
67% of the 45 Companies
in the Global Medical Devices industry.

( Industry Median: 41.87 vs. STJ: 33.81 )
Ranked among companies with meaningful Shiller P/E only.
STJ' s Shiller P/E Range Over the Past 10 Years
Min: 17.31  Med: 30.39 Max: 57.55
Current: 33.81
17.31
57.55
Current Ratio 1.72
STJ's Current Ratio is ranked lower than
74% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 2.83 vs. STJ: 1.72 )
Ranked among companies with meaningful Current Ratio only.
STJ' s Current Ratio Range Over the Past 10 Years
Min: 1.14  Med: 2.56 Max: 4.53
Current: 1.72
1.14
4.53
Quick Ratio 1.15
STJ's Quick Ratio is ranked lower than
75% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 2.05 vs. STJ: 1.15 )
Ranked among companies with meaningful Quick Ratio only.
STJ' s Quick Ratio Range Over the Past 10 Years
Min: 0.86  Med: 1.88 Max: 3.54
Current: 1.15
0.86
3.54
Days Inventory 168.33
STJ's Days Inventory is ranked lower than
65% of the 279 Companies
in the Global Medical Devices industry.

( Industry Median: 134.88 vs. STJ: 168.33 )
Ranked among companies with meaningful Days Inventory only.
STJ' s Days Inventory Range Over the Past 10 Years
Min: 146.43  Med: 162.13 Max: 177.06
Current: 168.33
146.43
177.06
Days Sales Outstanding 83.76
STJ's Days Sales Outstanding is ranked lower than
64% of the 270 Companies
in the Global Medical Devices industry.

( Industry Median: 68.74 vs. STJ: 83.76 )
Ranked among companies with meaningful Days Sales Outstanding only.
STJ' s Days Sales Outstanding Range Over the Past 10 Years
Min: 78.88  Med: 91.70 Max: 98.89
Current: 83.76
78.88
98.89
Days Payable 55.07
STJ's Days Payable is ranked lower than
55% of the 262 Companies
in the Global Medical Devices industry.

( Industry Median: 62.25 vs. STJ: 55.07 )
Ranked among companies with meaningful Days Payable only.
STJ' s Days Payable Range Over the Past 10 Years
Min: 33.34  Med: 58.78 Max: 77.02
Current: 55.07
33.34
77.02

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.45
STJ's Dividend Yield is ranked lower than
56% of the 168 Companies
in the Global Medical Devices industry.

( Industry Median: 1.58 vs. STJ: 1.45 )
Ranked among companies with meaningful Dividend Yield only.
STJ' s Dividend Yield Range Over the Past 10 Years
Min: 0.39  Med: 1.71 Max: 2.81
Current: 1.45
0.39
2.81
Dividend Payout 0.47
STJ's Dividend Payout is ranked lower than
65% of the 112 Companies
in the Global Medical Devices industry.

( Industry Median: 0.34 vs. STJ: 0.47 )
Ranked among companies with meaningful Dividend Payout only.
STJ' s Dividend Payout Range Over the Past 10 Years
Min: 0.28  Med: 0.32 Max: 0.94
Current: 0.47
0.28
0.94
Dividend Growth (3y) 8.00
STJ's Dividend Growth (3y) is ranked lower than
55% of the 76 Companies
in the Global Medical Devices industry.

( Industry Median: 9.10 vs. STJ: 8.00 )
Ranked among companies with meaningful Dividend Growth (3y) only.
STJ' s Dividend Growth (3y) Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 8.7
Current: 8
0
8.7
Forward Dividend Yield 1.49
STJ's Forward Dividend Yield is ranked lower than
59% of the 158 Companies
in the Global Medical Devices industry.

( Industry Median: 1.67 vs. STJ: 1.49 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 1.45
STJ's Yield on cost (5-Year) is ranked lower than
60% of the 197 Companies
in the Global Medical Devices industry.

( Industry Median: 1.92 vs. STJ: 1.45 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
STJ' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0.39  Med: 1.71 Max: 2.81
Current: 1.45
0.39
2.81
3-Year Average Share Buyback Ratio 1.50
STJ's 3-Year Average Share Buyback Ratio is ranked higher than
92% of the 204 Companies
in the Global Medical Devices industry.

( Industry Median: -3.30 vs. STJ: 1.50 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
STJ' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -2  Med: 1.50 Max: 4.2
Current: 1.5
-2
4.2

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 1.93
STJ's Price/Projected FCF is ranked higher than
57% of the 129 Companies
in the Global Medical Devices industry.

( Industry Median: 2.23 vs. STJ: 1.93 )
Ranked among companies with meaningful Price/Projected FCF only.
STJ' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.91  Med: 1.60 Max: 5.41
Current: 1.93
0.91
5.41
Price/DCF (Earnings Based) 2.22
STJ's Price/DCF (Earnings Based) is ranked lower than
55% of the 20 Companies
in the Global Medical Devices industry.

( Industry Median: 2.17 vs. STJ: 2.22 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.33
STJ's Price/Median PS Value is ranked lower than
66% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 1.05 vs. STJ: 1.33 )
Ranked among companies with meaningful Price/Median PS Value only.
STJ' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.6  Med: 1.08 Max: 2.13
Current: 1.33
0.6
2.13
Earnings Yield (Greenblatt) (%) 2.95
STJ's Earnings Yield (Greenblatt) (%) is ranked higher than
68% of the 341 Companies
in the Global Medical Devices industry.

( Industry Median: -0.40 vs. STJ: 2.95 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
STJ' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 2.95  Med: 5.20 Max: 9.9
Current: 2.95
2.95
9.9
Forward Rate of Return (Yacktman) (%) 6.63
STJ's Forward Rate of Return (Yacktman) (%) is ranked lower than
53% of the 117 Companies
in the Global Medical Devices industry.

( Industry Median: 7.42 vs. STJ: 6.63 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
STJ' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 5.3  Med: 19.00 Max: 24.3
Current: 6.63
5.3
24.3

More Statistics

Revenue (TTM) (Mil) $5,796
EPS (TTM) $ 2.30
Beta1.14
Short Percentage of Float2.92%
52-Week Range $48.83 - 83.52
Shares Outstanding (Mil)284.28

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 6,041 6,354 6,943
EPS ($) 4.03 4.42 4.93
EPS w/o NRI ($) 4.03 4.42 4.93
EPS Growth Rate
(3Y to 5Y Estimate)
4.76%
Dividends Per Share ($) 1.08 1.12 1.42
» More Articles for STJ

Headlines

Articles On GuruFocus.com
Johnson & Johnson Reports 4% Sales Growth for the Second Quarter Jul 22 2016 
Opinions Differ on Abbott Deal to Acquire St. Jude's Medical Jun 18 2016 
Mairs and Power Boosts Holdings in Hormel Foods Mar 19 2016 
Jeff Auxier Takes Plunge in Fastenal, a Stock From Watchlist Feb 10 2016 
Weekly 52-Week Highs Highlight: GILD, XL, STJ, NKE Jun 20 2015 
Weekly Insider Sells Highlight: JNJ, TRV, AAL, STJ May 03 2015 
Reversing a Declining Pattern in Earnings Per Share Feb 24 2015 
Medtronic Q3 Earnings 2015 Exceeds Market Expectations Feb 19 2015 
Stocks Clocking Record Dividend Hike Feb 17 2015 
A Robust Q4 Earnings Report From Boston Scientific Feb 10 2015 

More From Other Websites
Boston Scientific’s Stock Surged after 2Q16 Earnings Jul 29 2016
Johnson & Johnson Reports 4% Sales Growth for the Second Quarter Jul 22 2016
ETF’s with exposure to St. Jude Medical, Inc. : July 22, 2016 Jul 22 2016
St. Jude Medical Gets ‘Hold’ Rating from 96% of Analysts Jul 22 2016
How St. Jude Medical Beat 2Q16 Wall Street Estimates Jul 22 2016
Did Hedge Funds Anticipate These M&A Deals? Jul 22 2016
St. Jude Medical, Inc. :STJ-US: Earnings Analysis: Q2, 2016 By the Numbers : July 21, 2016 Jul 21 2016
WeissLaw LLP Files Class Action Lawsuit Against St. Jude Medical, Inc. Jul 20 2016
[$$] Abbott Labs Profit Tops Views Jul 20 2016
Abbott's Alere Deal Continues To Face Uncertainty Jul 20 2016
Edited Transcript of STJ earnings conference call or presentation 20-Jul-16 12:00pm GMT Jul 20 2016
St. Jude Medical, Stepan Company & Three Other Stocks Trending on Strong Quarterly Results Jul 20 2016
[$$] St. Jude Medical Logs Double-Digit Sales Growth Jul 20 2016
St. Jude Medical (STJ) Meets Q2 Earnings, Withdraws Outlook Jul 20 2016
St. Jude Medical Up Slightly as It Meets Estimates Jul 20 2016
Abbott sales beat on higher demand for medical devices Jul 20 2016
St. Jude Medical's (STJ) Q2 Earnings In Line, Sales Beat Jul 20 2016
5 Merger Arb Plays Added to Havens Advisors’ Portfolio in Q2 Jul 20 2016
St. Jude Medical Reports In Line Q2 Results Jul 20 2016
ST JUDE MEDICAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jul 20 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)